Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

The global single-use assemblies market, valued at US$ 2.52 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, reaching US$ 2.63 billion in 2024 and an impressive US$ 4.89 billion by ...

The global single-use assemblies market, valued at US$ 2.52 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, reaching US$ 2.63 ...

Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

FusionLayer Inc. announced FusionLayer Xverse, a next-generation solution designed to transform security and infrastructure service deployment at the network edge. Xverse combines seamless, secure ...

Novo Holdings, the controlling shareholder of Novo Nordisk, hopes to double the size of its recently acquired contract drugmaker Catalent over five years, a senior partner at the investment firm said, ...

Ataccama is a data quality company that helps organisations organise, understand and improve their data. The company recently ...

"But doubling the size of your business over five years ... Catalent and Thermo Fisher Scientific (TMO.N), opens new tab unit Patheon -- two of the largest contract drug manufacturers based ...

British Steel has today announced the opening of a new £26-million service centre, as part of the company’s special profiles business in Skinningrove ... Read how these and other technologies from ...

- 08:15 (EU) ECB Interest Rate Decision: Expected to cut Key Rates by 25bps; Expected to cut Deposit Rate by 25bps to 2.75%; Expected to cut Main 7-Day Refinancing Rate by 25bps to 2.90%; Expected to ...

today announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying ...